Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

Biogen (NASDAQ:BIIB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Biogen (BIIB) operate in?

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.

Open	$229.45
Close	$224.61
Volume / Avg.	580.74K / 1.15M
Day Range	222.74 - 229.45
52 Wk Range	189.44 - 287.60
Market Cap	$32.70B
P/E Ratio	28.60
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	2.38%
Days to Cover	3.24

Recent News

Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst

The FDA has approved Eli Lilly's Kisunla (donanemab) for early symptomatic Alzheimer's disease. Kisunla, targeting amyloid plaques, shows a significant reduction in disease progression and may reduce treatment costs with fewer infusions. Priced at $32,000 annually, it offers a competitive option against Biogen's Leqembi.

Vandana Singh

Denali Outperforms Industry in 3 Months: Here's Why

Denali Therapeutics Inc. (NASDAQ: DNLI) is having a good run in 2024. Shares of this biopharmaceutical company have risen 11.9% in the past three months against the industry's decline of 6%.

Zacks

Is the Options Market Predicting a Spike in Biogen Stock?

Investors in Biogen Inc. (NASDAQ: BIIB) need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $120.00 Call had some of the highest implied volatility of all equity options today.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Biogen Inc

Sector

Health Care

Industry

Biotechnology

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex a...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Biogen (BIIB) stock?

You can purchase shares of Biogen (NASDAQ:BIIB) through any online brokerage.

View our list of the best stock brokerages

Who are Biogen (BIIB) competitors?

Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for Biogen (BIIB) stock?

There is no analysis for Biogen.

What is the forecast for Biogen (BIIB) stock?

Biogen has a consensus price target of $291.84.

Current stock price for Biogen (BIIB)?

The stock price for Biogen (NASDAQ: BIIB) is $224.61 last updated July 3, 2024 at 1:06 PM EDT.

Does Biogen (BIIB) pay a dividend?

There are no upcoming dividends for Biogen.

When is Biogen (NASDAQ:BIIB) reporting earnings?

Biogen’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Biogen (BIIB) going to split?

There is no upcoming split for Biogen.

What sector and industry does Biogen (BIIB) operate in?

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Biogen

Biogen (BIIB) Forecast